Trial Profile
A Phase 1, Open-Label Study to Evaluate the Absorption, Metabolism, and Excretion of [14C]-BIIB074 in Healthy Male Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Apr 2021
Price :
$35
*
At a glance
- Drugs Vixotrigine (Primary)
- Indications Neuropathic pain; Trigeminal neuralgia
- Focus Pharmacokinetics
- Sponsors Biogen
- 29 Mar 2021 Results of Population PK model analysis from 12 clinical studies: SCB107718, SCB107727, SCB113210, SCB113210, 802HV101, 802HV102, 802HV104, 802HV105, 802HV106, 802HV107, 1014802/202, 1014802/201 and 1014802/205 published in the European Journal of Drug Metabolism and Pharmacokinetics
- 15 Jun 2016 Status changed from not yet recruiting to completed.
- 28 Apr 2016 New trial record